References:
1. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24(2):235-258.
2. Farquhar C. Endometriosis. Bmj. 2007;334(7587):249-253.
3. Giudice LC. Clinical practice. Endometriosis. N Engl J Med.2010;362(25):2389-2398.
4. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study–Part 1. Bjog. 2008;115(11):1382-1391.
5. Prescott J, Farland LV, Tobias DK, et al. A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod.2016;31(7):1475-1482.
6. Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecol Obstet Invest.2017;82(5):453-461.
7. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366-373.e368.
8. Kuznetsov L, Dworzynski K, Davies M, Overton C. Diagnosis and management of endometriosis: summary of NICE guidance. Bmj.2017;358:j3935.
9. Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9.
10. Rogers PAW, D’Hooghe TM, Fazleabas A, et al. Priorities for endometriosis research: Recommendations from an international consensus workshop. Reproductive Sciences. 2009;16(4):335-346.
11. Rogers PA, Adamson GD, Al-Jefout M, et al. Research Priorities for Endometriosis. Reprod Sci. 2017;24(2):202-226.
12. Arruda MS, Petta CA, Abrão MS, Benetti-Pinto CL. Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod. 2003;18(4):756-759.
13. Surrey E, Soliman AM, Trenz H, Blauer-Peterson C, Sluis A. Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs. Adv Ther. 2020;37(3):1087-1099.
14. UK All Party Parliamentary Group on Endometriosis Inquiry Report.Endometriosis in the UK: time for change (October 2020). UK All Party Parliamentary Group on Endometriosis;2020.
15. Liu E, Nisenblat V, Farquhar C, et al. Urinary biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database of Systematic Reviews. 2015;2015(12).
16. Gupta D, Hull ML, Fraser I, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4(4):Cd012165.
17. Nisenblat V, Prentice L, Bossuyt PM, Farquhar C, Hull ML, Johnson N. Combination of the non-invasive tests for the diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;7(7):Cd012281.
18. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: A systematic review.Human Reproduction Update. 2010;16(6):651-674.
19. Nisenblat V, Prentice L, Bossuyt PMM, Farquhar C, Hull ML, Johnson N. Combination of the non-invasive tests for the diagnosis of endometriosis. Cochrane Database of Systematic Reviews.2016;2016(7).
20. Nisenblat V, Bossuyt PMM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database of Systematic Reviews. 2016;2016(5).
21. Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis.Cochrane Database Syst Rev. 2016;2(2):Cd009591.
22. Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol.2019;220(4):354.e351-354.e312.
23. Surrey E, Carter CM, Soliman AM, Khan S, DiBenedetti DB, Snabes MC. Patient-completed or symptom-based screening tools for endometriosis: a scoping review. Arch Gynecol Obstet. 2017;296(2):153-165.
24. Fauconnier A, Drioueche H, Huchon C, et al. Early identification of women with endometriosis by means of a simple patient-completed questionnaire screening tool: a diagnostic study. Fertil Steril.2021;116(6):1580-1589.
25. Bruggmann D, Elizabeth-Martinez A, Klingelhofer D, Quarcoo D, Jaque J, Groneberg D. Endometriosis and its global research architecture: an in-depth density-equalizing mapping analysis. Bmc Womens Health.2016;16.
26. Malvezzi H, Marengo EB, Podgaec S, Piccinato CA. Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology. J Transl Med. 2020;18(1):311.
27. Bainton T JS, Raza A. A systematic review of the literature to determine the accuracy measures of various predictors of endometriosis.https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=187543 . Published 2020. Accessed.
28. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj.2021;372:n71.
29. EndNote [computer program]. Version EndNote X9. Philadelphia, PA: Clarivate; 2013.
30. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536.
31. StataCorp. 2017. Stata Statistical Software: Release 15. College Station TSL.
32. Hediger ML, Hartnett HJ, Louis GM. Association of endometriosis with body size and figure. Fertil Steril. 2005;84(5):1366-1374.
33. Paiva P, Lappas M, Barker G, Healey M. Using symptom scores, lifestyle measures and biochemical markers to create a test for endometriosis. Journal of Endometriosis and Pelvic Pain Disorders. 2014;6(3):135-143.
34. Backonja U, Hediger ML, Chen Z, et al. Beyond Body Mass Index: Using Anthropometric Measures and Body Composition Indicators to Assess Odds of an Endometriosis Diagnosis. J Womens Health (Larchmt).2017;26(9):941-950.
35. Tanmahasamut P, Preukthanathorn R, Dangrat C. Serum interleukin 6 and cancer antigen 125 in the non-invasive diagnosis of endometriosis.Journal of Endometriosis and Pelvic Pain Disorders.2018;10(2):116-122.
36. Kim H, Choi YS, Kim JS, et al. Identification of Serum Biomarkers for Diagnosis of Endometriosis Using Multiplex Immunoassays.Reproductive Sciences. 2020;27(5):1139-1147.
37. Chapron C, Barakat H, Fritel X, Dubuisson JB, Bréart G, Fauconnier A. Presurgical diagnosis of posterior deep infiltrating endometriosis based on a standardized questionnaire. Hum Reprod.2005;20(2):507-513.
38. Kazanegra R, Zaritsky E, Lathi RB, Clopton P, Nezhat C. Diagnosis of stage I endometriosis: comparing visual inspection to histologic biopsy specimen. J Minim Invasive Gynecol. 2008;15(2):176-180.
39. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod.2014;29(3):400-412.
40. Lier MCI, Vlek SL, Ankersmit M, et al. Comparison of enhanced laparoscopic imaging techniques in endometriosis surgery: a diagnostic accuracy study. Surg Endosc. 2020;34(1):96-104.
41. Chen CX, Kwekkeboom KL, Ward SE. Self-report pain and symptom measures for primary dysmenorrhoea: a critical review. Eur J Pain. 2015;19(3):377-391.
42. Doggweiler R, Whitmore KE, Meijlink JM, et al. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society.Neurourol Urodyn. 2017;36(4):984-1008.
43. Steingrímsdóttir Ó A, Landmark T, Macfarlane GJ, Nielsen CS. Defining chronic pain in epidemiological studies: a systematic review and meta-analysis. Pain. 2017;158(11):2092-2107.
44. Liu Y, Zhang W. Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget.2017;8(29):46928-46936.
45. Yi KW, Shin JH, Park MS, Kim T, Kim SH, Hur JY. Association of body mass index with severity of endometriosis in Korean women. Int J Gynaecol Obstet. 2009;105(1):39-42.
46. Shafrir AL, Wise LA, Palmer JR, et al. Validity of self-reported endometriosis: a comparison across four cohorts. Hum Reprod.2021;36(5):1268-1278.
47. Seracchioli R, Mabrouk M, Guerrini M, et al. Dyschezia and posterior deep infiltrating endometriosis: analysis of 360 cases. J Minim Invasive Gynecol. 2008;15(6):695-699.
48. Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005;11(6):595-606.
49. May KE, Villar J, Kirtley S, Kennedy SH, Becker CM. Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update. 2011;17(5):637-653.
50. Rogozińska E, Khan K. Grading evidence from test accuracy studies: what makes it challenging compared with the grading of effectiveness studies? Evid Based Med. 2017;22(3):81-84.
51. Eskenazi B, Warner M, Bonsignore L, Olive D, Samuels S, Vercellini P. Validation study of nonsurgical diagnosis of endometriosis.Fertil Steril. 2001;76(5):929-935.
52. Madhvani K, Fernandez-Felix BM, Zamora J, Carpenter T, Khan KS. Personalising the risk of conversion from laparoscopic to open hysterectomy in benign conditions: Development and external validation of risk prediction models. Bjog. 2021.
53. Hirsch M, Duffy JMN, Davis CJ, et al. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis.BJOG Int J Obstet Gynaecol. 2016;123(11):1761-1768.
54. Nnoaham KE, Hummelshoj L, Kennedy SH, Jenkinson C, Zondervan KT. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril. 2012;98(3):692-701.e695.
55. Chapron C, Lafay-Pillet MC, Santulli P, et al. A new validated screening method for endometriosis diagnosis based on patient questionnaires. EClinicalMedicine. 2022;44:101263.